Putnam Investments’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $268K | Sell |
1,945
-29
| -1% | -$3.81K | ﹤0.01% | 1101 |
|
|
2023
Q3 | $241K | Sell |
1,974
-21
| -1% | -$2.8K | ﹤0.01% | 1108 |
|
|
2023
Q2 | $280K | Sell |
1,995
-88
| -4% | -$12.1K | ﹤0.01% | 1099 |
|
|
2023
Q1 | $295K | Sell |
2,083
-611
| -23% | -$87.4K | ﹤0.01% | 1083 |
|
|
2022
Q4 | $421K | Buy |
+2,694
| New | +$387K | ﹤0.01% | 972 |
|
|
2021
Q1 | – | Sell |
-5,017
| Closed | -$598K | – | 788 |
|
|
2020
Q4 | $598K | Sell |
5,017
-15,972
| -76% | -$1.95M | ﹤0.01% | 724 |
|
|
2020
Q3 | $2.4M | Sell |
20,989
-361
| -2% | -$42.7K | ﹤0.01% | 615 |
|
|
2020
Q2 | $2.43M | Sell |
21,350
-2,723
| -11% | -$289K | 0.01% | 627 |
|
|
2020
Q1 | $1.93M | Sell |
24,073
-461
| -2% | -$47.7K | 0.01% | 625 |
|
|
2019
Q4 | $2.62M | Sell |
24,534
-467
| -2% | -$48.7K | 0.01% | 693 |
|
|
2019
Q3 | $2.67M | Buy |
25,001
+4,142
| +20% | +$425K | 0.01% | 668 |
|
|
2019
Q2 | $2.12M | Sell |
20,859
-532
| -2% | -$51.1K | ﹤0.01% | 718 |
|
|
2019
Q1 | $1.92M | Sell |
21,391
-15,937
| -43% | -$1.38M | ﹤0.01% | 697 |
|
|
2018
Q4 | $3.11M | Buy |
+37,328
| New | +$3.5M | 0.01% | 559 |
|
|
2018
Q3 | – | Sell |
-1,857
| Closed | -$204K | – | 1080 |
|
|
2018
Q2 | $204K | Sell |
1,857
-281
| -13% | -$29.3K | ﹤0.01% | 1053 |
|
|
2018
Q1 | $214K | Hold |
2,138
| – | – | ﹤0.01% | 1066 |
|
|
2017
Q4 | $211K | Sell |
2,138
-400
| -16% | -$37.9K | ﹤0.01% | 1063 |
|
|
2017
Q3 | $238K | Sell |
2,538
-100
| -4% | -$10.6K | ﹤0.01% | 1072 |
|
|
2017
Q2 | $293K | Sell |
2,638
-239
| -8% | -$25.3K | ﹤0.01% | 1033 |
|
|
2017
Q1 | $282K | Sell |
2,877
-100
| -3% | -$9.53K | ﹤0.01% | 1181 |
|
|
2016
Q4 | $274K | Sell |
2,977
-200
| -6% | -$17.2K | ﹤0.01% | 1191 |
|
|
2016
Q3 | $269K | Hold |
3,177
| – | – | ﹤0.01% | 1196 |
|
|
2016
Q2 | $259K | Hold |
3,177
| – | – | ﹤0.01% | 1282 |
|
|
2016
Q1 | $227K | Hold |
3,177
| – | – | ﹤0.01% | 1357 |
|
|
2015
Q4 | $226K | Buy |
+3,177
| New | +$214K | ﹤0.01% | 1414 |
|
|
2015
Q3 | – | Sell |
-3,477
| Closed | -$252K | – | 1491 |
|
|
2015
Q2 | $252K | Sell |
3,477
-500
| -13% | -$36.9K | ﹤0.01% | 1449 |
|
|
2015
Q1 | $306K | Buy |
3,977
+209
| +6% | +$15K | ﹤0.01% | 1400 |
|
|
2014
Q4 | $253K | Sell |
3,768
-2,388
| -39% | -$151K | ﹤0.01% | 1413 |
|
|
2014
Q3 | $374K | Hold |
6,156
| – | – | ﹤0.01% | 1411 |
|
|
2014
Q2 | $361K | Sell |
6,156
-46,000
| -88% | -$2.69M | ﹤0.01% | 1380 |
|
|
2014
Q1 | $3.02M | Sell |
52,156
-192,918
| -79% | -$10.3M | 0.01% | 946 |
|
|
2013
Q4 | $13.1M | Sell |
245,074
-11,821
| -5% | -$701K | 0.03% | 393 |
|
|
2013
Q3 | $15.9M | Sell |
256,895
-5,656
| -2% | -$339K | 0.04% | 352 |
|
|
2013
Q2 | $15.9M | Buy |
+262,551
| New | +$15.6M | 0.05% | 333 |
|
Other funds holding DGX
DSA
Putnam Investments's DGX Position: Q4 2023 in Review
Putnam Investments reduced its Quest Diagnostics (DGX) stake by 1.5% in Q4 2023, selling an estimated $3.81K and leaving 1,945 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #1101.
Putnam Investments first reported a position in DGX in Q2 2013 and has held it in 34 quarters since. The position peaked at $15.9M in Q2 2013. 826 funds tracked by Wall St. Rank hold DGX as of Q4 2023.
- Putnam Investments held 1,945 shares of Quest Diagnostics worth $268K as of Q4 2023.
- Putnam Investments sold 29 Quest Diagnostics shares in Q4 2023, an estimated $3.81K.
- Quest Diagnostics made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #1101 holding.
- Putnam Investments first reported a position in Quest Diagnostics in Q2 2013 and has held it in 34 quarters since.
- Putnam Investments's Quest Diagnostics position peaked at $15.9M in Q2 2013.
- 826 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.
Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.